Fattening Doctors To Promote Weight Loss Drugs

In order to promote its weight-loss and diabetes drugs, Novo Nordisk bought doctors almost a half a million meals in 2022.

Related Keywords

Canada ,United States ,Americans ,Eli Lilly ,Nick Florkopic ,Ozempic Wegovy ,Johnl Lamattina ,Novo Nordisk ,Physician Payment Sunshine Act ,Affordable Care Act ,Balancing Innovation ,Drug Prices ,Ozempic ,Glp 1 ,